Latest

Latest therapeutics News

  • Latest therapeutics news stories and updates. What is happening today? All recent therapeutics news and developments. Live coverage and timeline of therapeutics. All you need to know about therapeutics.
BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics
Chemical pollutants can change your skin bacteria and increase your eczema risk − new research explores how
Swinburne and UIIN showcase university-industry collaboration
Seaport Therapeutics receives $100 million in funding to maximise Monash invention
AusBiotech Welcomes Medical Science Co-Investment Plan
Breakthrough Discovery In Fight Against Liver Disease
Seaport Therapeutics receives $100 million in funding to maximise Monash invention
Starpharma partners with UK investment firm to create Petalion Therapeutics
Breakthrough Test Can Evaluate Enzyme Involved in Process Associated with Cancer Cell Death
Opthea Appoints Sujal Shah To Its Board Of Directors
Percheron Therapeutics provides update on ATL1102 Duchenne muscular dystrophy trial
Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization
New Hope In Immunotherapy Against Cancer
Stakeholder Forum – Health Professional Education and Consumer Health Literacy
Monash University pharmaceutical scientists honoured in NHMRC Research Excellence Awards
Gut microbiota and antibiotics: Missing puzzle piece discovered
Consortium identifies 5 grand challenges in biomedical engineering
Study Shines New Light On Immune Response
Dash Heath-Paynter confirmed as Health Equity Matters CEO
What you need to know about new treatments for children with peanut allergies
Mediterranean diet could help people with irritable bowel symptoms
Using generative AI assistant to interpret pharmacogenetic test results
Completing First 100 Days Plan
Australian Institute For Infectious Disease One Step Closer
Fast Five With Mark Vidallon
Sustainable innovation: Intellectual property, technology transfer, and global public goods
Certa Therapeutics’ FT011 granted US FDA fast track for systemic sclerosis
Trial shows ‘wonder’ material can be developed safely
Improving screening of new drugs inspires QUT Fulbright Scholar
Capping off a year of generosity
Discovery could lead to new RNA therapeutics for many cancers
Brandon BioCatalyst, in partnership with ANDHealth, selected by Federal Government to deliver $50m Dementia and Cognitive Decline Incubator
Scientists help discover new treatment for many cancers
Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
T cells team-up to protect the liver from infection
Vaccine shows promise against CMV, a virus that causes birth defects
First patient receives treatment in Chimeric’s trial of CHM 0201 in AML
The updated WHO Benchmarks for Strengthening Health Emergency Capacities expanded to include public health and social measures (PHSM)
Positive high-level results from Japan Phase III trial of acoramidis in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) showed consistency with global ATTRibute-CM…
Better treatments sooner – Hudson’s new RNAte Platform unveiled
Investing In World-First Tech For Vaccine Development
WHO and MPP announce technology transfer license to enable greater patient access to multiple essential diagnostics
Arovella licences novel CARiNKT cell armouring technology
Structural study points way to better malaria drugs
Chimeric Therapeutics completes placement with shortfall commitments
​​CSIRO launches free program for SMEs innovating in Digital Health and Medical Technology​
Combo treatment improves lung cancer outcomes
Mice without immune cells show no SARS-CoV-2 symptoms

© 2024 - The National Tribune Australia